Results 101 to 110 of about 761,048 (226)
Clinical and Translational Discovery, Volume 6, Issue 5, October 2026.Current Management & Limitations: Traditional auditory devices lack genetic curative potential and yield variable, non‐physiological hearing outcomes. OTOF gene therapy has shown promising clinical outcomes with dual‐AAV therapy. GJB2 gene therapy remains an emerging approach with significant translational challenges. Advances in vector design and cell‐
Jiahui Zhao, Mengzhao Xun, Yu Sun
wiley +1 more source
, 2018 Auditory-evoked potentials have proven useful in the objective evaluation of sound encoding at different stages of the auditory pathway (brainstem and cortex).
Pousson, Monique +7 more
core +1 more source
Study of auditory pathways in type 1 diabetes mellitus through brainstem auditory evoked potentials and contralateral acoustic reflex. [PDF]
Codas, 2023 Fernandes LDC +3 more
europepmc +1 more source
Developmental Neurobiology, Volume 86, Issue 4, October 2026.ABSTRACT Individuals with fetal alcohol spectrum disorders exhibit impaired auditory processing and atypical auditory behaviors across the disorder's spectrum. Although low to moderate prenatal alcohol exposure (PAE) is a prevalent type of exposure, the developmental trajectory of auditory processing deficits resulting from this level of exposure ...
Michael Douchey +3 more
wiley +1 more source
Assessment of Visual and Brainstem Auditory Evoked Potentials in Patients with Hashimoto's Thyroiditis. [PDF]
J Immunol Res, 2021 Waliszewska-Prosół M, Ejma M.
europepmc +1 more source
Small Molecule Therapeutic Approaches With a Greater Focus on Hearing Loss: A Review
Health Science Reports, Volume 9, Issue 10, October 2026.ABSTRACT Background and Aims Hearing loss (HL) is one of the most common sensory impairments worldwide and has substantial effects on quality of life and daily functioning. Although cochlear implants and hearing aids have markedly improved the management of hearing impairment, these devices do not directly address the underlying pathogenic mechanisms ...
Maryam Naghinejad +5 more
wiley +1 more source
Smart Medicine, Volume 5, Issue 5, October 2026.AC591 and its core active component 18β‐glycyrrhetinic acid effectively alleviate cisplatin‐induced ototoxicity by binding p53 and suppressing p53‐mediated ferroptosis, representing promising agents for preventing cisplatin‐related hearing loss. ABSTRACT Cisplatin is a widely utilized chemotherapeutic agent for the treatment of malignant cancers ...
Yunhao Wu +9 more
wiley +1 more source
Aging Cell, Volume 25, Issue 10, October 2026.IGF‐1/SLC25A33–TGF‐β/Smad2 axis can regulate pericyte activation and BLB integrity, which may be a potential therapeutic target for preserving hearing in ARHL. ABSTRACT Age‐related hearing loss (ARHL) is a prevalent sensory disorder in the elderly, yet the molecular mechanisms underlying cochlear aging remain incompletely understood. While insulin‐like
Rui Xu +9 more
wiley +1 more source
Brainstem auditory evoked potentials in patients with primary Sjögren's syndrome without central nervous system involvement. [PDF]
Clin Rheumatol, 2021 Waliszewska-Prosół M +5 more
europepmc +1 more source
European Journal of Neuroscience, Volume 64, Issue 7, October 2026.Deviance detection (DD) emerges in dissociated cortical cultures around DIV15 and remains detectable through maturation. Near‐critical network dynamics are associated with stronger DD responses. Early structured stimulation was associated with descriptive differences in response timing and DD strength, although mature‐stage group differences were not ...
Zhuo D. Zhang +5 more
wiley +1 more source